Opiant Pharmaceuticals Inc (OPNT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
20.65 -0.12 (-0.58%) 03/01/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 20.65 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,009 | -1,861 | 11,593 | -21,195 | N/A |
| Depreciation Amortization | 930 | 625 | 238 | 3 | N/A |
| Accounts receivable | -4,416 | -1,693 | -2,729 | 7,207 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 361 | -1,924 | N/A |
| Other Working Capital | -4,760 | -3,072 | -10,948 | 14,127 | N/A |
| Other Operating Activity | 7,165 | 3,972 | 5,549 | 1,259 | 0 |
| Operating Cash Flow | $1,927 | $-2,029 | $4,064 | $-523 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -51 | -303 | N/A | N/A |
| Purchase Of Investment | -15,015 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-15,015 | $-51 | $-303 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,719 | 20,685 | 2,675 | 17,187 | N/A |
| Other Financing Activity | 0 | -1,316 | -70 | -166 | 0 |
| Financing Cash Flow | $2,719 | $19,369 | $2,605 | $17,021 | $N/A |
| Exchange Rate Effect | -28 | -19 | N/A | N/A | N/A |
| Beginning Cash Position | 48,251 | 30,981 | 24,614 | 8,116 | N/A |
| End Cash Position | 37,854 | 48,251 | 30,981 | 24,614 | N/A |
| Net Cash Flow | $-10,397 | $17,271 | $6,367 | $16,498 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,927 | -2,029 | 4,064 | -523 | N/A |
| Capital Expenditure | N/A | -51 | -303 | N/A | N/A |
| Free Cash Flow | 1,927 | -2,080 | 3,761 | -523 | 0 |